Agenda
The following agenda is for the 2026 IHE Indy Precision Oncology Symposium.
Saturday, August 29th, 2026
| Time | Event/Topic |
|---|---|
| 6:00 AM - 7:10 AM | Registration |
| 7:10 AM - 7:55 AM | Breakfast Product Theater |
| 8:00 AM - 8:30 AM | Introduction and Welcome: Precision Oncologics in Hematologic Malignancies Ruemu Birhiray, MD Clinical Professor of Medicine Marian University – Wood College of Osteopathic Medicine |
| 8:30 AM - 9:00 AM | Precision Oncology Diagnostics: From Biomarker Identification To Clinical Application Anil Sood, MD Professor and Vice Chair for Translational Research in Gynecologic Oncology and Cancer Biology MD Anderson Cancer Center |
| 9:00 AM - 9:30 AM | Advances in Molecularly Targeted Treatment for CNS Malignancies Patrick Y. Wen, MD Director for the Center for Neuro-Oncology Dana-Farber Cancer Institute |
| 9:30 AM - 9:40 AM | Diagnostics and CNS Malignancies Questions and Answers |
| 9:40 AM - 9:55 AM | Coffee Break in Exhibitor Hall |
| 9:55 AM - 10:25 AM | Targeting Oncogenic Drivers in Lung Cancer: The Role of TK Inhibitors Justin F. Gainor, MD Associate Professor of Medicine Harvard Medical School |
| 10:25 AM - 10:55 AM | Immunologic Strategies for Management of Lung Cancer Alex Adjei, MD, PhD Chair of Cleveland Clinic Taussig Cancer Institute |
| 10:55 AM - 11:25 AM | Advancing Therapeutic Targets in Small Cell Lung Cancer Christine Hann, MD, PhD Associate Professor of Oncology John Hopkins School of Medicine |
| 11:25 AM - 11:40 AM | Lung Cancers Questions and Answers |
| 11:40 AM - 12:10 PM | Molecularly Driven Treatment Strategies in Gastrointestinal Oncology Heinz-Josef Lenz, MD Deputy Director for Research Programs USC Norris Comprehensive Cancer Center |
| 12:10 PM - 12:40 PM | Precision Oncology in Pancreato-Biliary Malignancies: Translating Molecular Insights into Therapy Aiwu (Ruth) He, MD, PhD Director of Hepatobiliary Cancer Columbia University Medical Center |
| 12:40 PM - 12:55 PM | Gastrointestinal Cancers Questions and Answers |
| 12:55 PM - 2:00 PM | Lunch |
| 2:00 PM - 2:30 PM | Targeted Treatment Strategies in GU Cancers: Current Advances and Emerging Approaches Scott T. Tagawa MD, MS, FACP, FASCO Medical Director of the Genitourinary Oncology Research Program Weill Cornell Medicine |
| 2:30 PM - 2:35 PM | Genitourinary Cancers Questions and Answers |
| 2:35 PM - 3:05 PM | Evolving Treatment Paradigms in Melanoma: Targeted and Immune-Based Approaches Michael A. Davies, MD, PhD Chair of the Department of Melanoma Medical Oncology MD Anderson Cancer Center |
| 3:05 PM - 3:10 PM | Skin Cancers Questions and Answers |
| 3:10 PM - 3:25 PM | Coffee Break in Exhibitor Hall |
| 3:25 PM - 3:55 PM | Overcoming Endocrine Resistance: Emerging Targets in HR+ Breast Cancer Ruth M. O'Regan, MD Chair of Medicine University of Rochester |
| 3:55 PM - 4:25 PM | Advancing HER2-Targeted Therapy: Translating Innovation into Practice Heather McArthur, MD, MPH, FASCO Clinical Director of the Breast Cancer Program University of Texas Southwestern Medical Center |
| 4:25 PM - 4:55 PM | Precision in Practice: When Molecular Testing in Breast Cancer Changes What You Do Senthil Damodaran, MD, PhD Associate Professor in the Department of Translational Molecular Pathology MD Anderson Cancer Center |
| 4:55 PM - 5:10 PM | Breast Cancers Questions and Answers |
| 5:10 PM - 5:40 PM | Gynecologic Cancers in the Precision Era: New Strategies, Real Impact Kathleen N. Moore, MD, MS Associate Director of Clinical Research The University of Oklahoma College of Medicine |
| 5:40 PM - 5:45 PM | Gynecologic Cancers Questions and Answers |